Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells

AG Brooks, F Borrego, PE Posch… - The Journal of …, 1999 - journals.aai.org
AG Brooks, F Borrego, PE Posch, A Patamawenu, CJ Scorzelli, M Ulbrecht, EH Weiss…
The Journal of Immunology, 1999journals.aai.org
The CD94/NKG2 receptors expressed by subpopulations of NK cells and T cells have been
implicated as receptors for a broad range of both classical and nonclassical HLA class I
molecules. To examine the ligand specificity of CD94/NKG2 proteins, a soluble
heterodimeric form of the receptor was produced and used in direct binding studies with
cells expressing defined HLA class I/peptide complexes. We confirm that CD94/NKG2A
specifically interacts with HLA-E and demonstrate that this interaction is dependent on the …
Abstract
The CD94/NKG2 receptors expressed by subpopulations of NK cells and T cells have been implicated as receptors for a broad range of both classical and nonclassical HLA class I molecules. To examine the ligand specificity of CD94/NKG2 proteins, a soluble heterodimeric form of the receptor was produced and used in direct binding studies with cells expressing defined HLA class I/peptide complexes. We confirm that CD94/NKG2A specifically interacts with HLA-E and demonstrate that this interaction is dependent on the association of HLA-E with peptide. Moreover, no interaction between CD94/NKG2A and classical HLA class I molecules was observed, as assayed by direct binding of the soluble receptor or by functional assays using CD94/NKG2A+ NK cells. The role of the peptide associated with HLA-E in the interaction between HLA-E and CD94/NKG2A was also assessed. All class I leader sequence peptides tested bound to HLA-E and were recognized by CD94/NKG2A. However, amino acid variations in class I leader sequences affected the stability of HLA-E. Additionally, not all HLA-E/peptide complexes examined were recognized by CD94/NKG2A. Thus CD94/NKG2A recognition of HLA-E is controlled by peptide at two levels; first, peptide must stabilize HLA-E and promote cell surface expression, and second, the HLA-E/peptide complex must form the ligand for CD94/NKG2A.
journals.aai.org